Journal of Diabetes Science and Technology (DST) is a bi-monthly, peer-reviewed scientific e-journal published by the Diabetes Technology Society, a non-profit organization. Our purpose is to promote the development and adoption of new products to help people with diabetes.
JDST covers all aspects of diabetes technology including: glucose monitoring; insulin and metabolic peptide delivery; the artificial and bioartificial pancreas, telemedicine; software for modeling; physiologic monitoring; technology for managing obesity; diagnostic tests of glycation; and the use of bioengineered tools such as MEMS, new biomaterials, and nanotechnology to develop new sensors and actuators to be applied to diabetes. Articles in DST will cover both basic research and clinical applications of technologies being developed to help people with diabetes.
JDST’s Editors, Editorial Board, Clinical Advisory Board, and staff aim to provide members of the diabetes technology community with information about the latest scientific and medical advances, as well as news of professional meetings and business developments in the field of diabetes technology. The importance of diabetes technology is increasing for the 200 million diabetes patients worldwide. JDST is a virtual meeting place for members of the diabetes technology community who: believe that technology can deliver great benefits to people with diabetes; want to read about what their peers are doing; and want to communicate with each other via Letters to the Editor, a type of format which will facilitate quick responses to posted letters.
JDST publishes Original Articles, Review Articles, Commentary Articles, Analysis Articles, Letters to the Editor, Proceedings of Diabetes Meetings, and regular columns devoted to business developments and the scientific and medical literature. The journal website provides the latest news stories and timely references from the medical literature.
JDST is the only journal that publishes the proceedings of the Diabetes Technology Meeting and the Clinical Diabetes Technology Meeting, as well as other diabetes meetings.
Those who subscribe to this electronic journal will have complete access to our News Section which includes the latest developments in research and business, plus important government announcements.
We at JDST hope you will find this journal informative, provocative, and even entertaining.
|Claudio Cobelli, PhD||University of Padova, Italy|
|Gerold M. Grodsky, PhD||University of California at San Francisco, USA|
|Boris Kovatchev, PhD||University of Virginia, USA|
|Lutz Heinemann, PhD||Science & Co.|
|Mark A. Arnold, PhD||University of Iowa, USA|
|Eirik Arsand, PhD||Norwegian Centre for Integrated Care and Telemedicine, Norway|
|Yael Barr, MD||NASA Johnson Space Center, USA|
|Riccardo Bellazzi, PhD||University of Pavia, Italy|
|B. Wayne Bequette, PhD||Rensselaer Polytechnic Institute, USA|
|Richard N. Bergman, PhD||Cedars-Sinai Medical Center, USA|
|Suzanne Austin Boren, PhD, MHA||University of Missouri, School of Medicine, Department of Health Management & Informatics, Columbia, MO, USA|
|Diane Burgess, PhD||University of Connecticut, USA|
|Robert D. Burk, MD||Albert Einstein College of Medicine, USA|
|George Cembrowski, MD, PhD||University of Alberta, Canada|
|Geoffrey Chase, PhD||University of Canterbury, New Zealand|
|Kong Chen, PhD||NIDDK, National Institutes of Health, USA|
|Chiara Dalla Man, PhD||University of Padova, Italy|
|Viera Donicova, M.D., Ph.D.||Faculty Hospital of L. Pasteura, Slovakia|
|Erik Dutson, MD||University of California Los Angeles, USA|
|Niels Ejskaer, MD, PhD||Aalborg University Hospital, Aalborg, Denmark|
|Abby G. Ershow, ScD||NHLBI, National Institutes of Health, USA|
|G. Alexander Fleming, MD||Kinexum, USA|
|Thomas Forst, MD||University of Mainz, Germany|
|Karl E. Friedl, PhD||University of California at San Francisco, USA|
|Brian Frier, BSc (Hons), MD, FRCP(Edin), FRCP(Glas)||The Queen's Medical Research Institute, University of Edinburgh, UK|
|Robert Gabbay MD, Ph.D.||Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA|
|Michael S. German, MD||Diabetes Technology Consultants|
|Barry H. Ginsberg, MD, PhD||Diabetes Technology Consultants|
|Richard W. Grant, MD, MPH||Kaiser Permanente, USA|
|Frank Greenway, MD, FACP||Pennington Biomedical Research Center, USA|
|Andrei Gribok, PhD||United States Department of Agriculture, USA|
|Warren S. Grundfest, MD, FACS||University of California Los Angeles, USA|
|Alberto Gutierrez, PhD||NDA Partners LLC, USA|
|Rubina Heptulla, MD||Albert Einstein College of Medicine, USA|
|Jeffrey I. Joseph, DO||Thomas Jefferson University, USA|
|Allen B. King, M.D., FACP, FACE||Diabetes Care Center|
|Robert Langer, ScD||Massachusetts Institute of Technology, USA|
|Dorian Liepmann, PhD||University of California at Berkeley, USA|
|Randie R. Little, PhD||University of Missouri, USA|
|Boris Mankovsky, MD||National Medical Academy for Postgraduate Education, Ukraine|
|V. Mohan, MD, FRCP, PhD, DSc, FNASc||Madras Diabetes Research Foundation, India|
|Shelagh Mulvaney, PhD||Vanderbilt University, USA|
|Danny Petrasek, MD, PhD||California Institute of Technology, USA|
|John Pickup, MD, PhD||Guy’s King’s & St. Thomas’ School of Medicine, UK|
|Leonard Pogach, MD||VA New Jersey Healthcare System, USA|
|Bruce Quinn, MD, JD||Foley Hoag LLP, USA|
|Sohi Rastegar, PhD||National Science Foundation, USA|
|Itamar Raz, MD||Hadassah University Hospital, Israel|
|David Rodbard, MD||Biomedical Informatics Consultants LLC|
|Jane Jeffrie Seley, DNP, MPH, MSN, BC-ADM, CDE||New York Presbyterian/Weill Cornell, USA|
|James Shapiro, MD, PhD||University of Alberta, Canada|
|Phil Smith, PhD||Centers for Disease Control and Prevention, USA|
|Koji Sode, PhD||Tokyo University of Agriculture & Technology, Japan|
|Jeffrey Sutton MD, PhD||National Space Biomedical Research Institute, USA|
|Mark True, MD||Wilford Hall Medical Center, USA|
|Stuart Weinzimer, MD||Yale University, USA|
|Elissa R. Weitzman, ScD, Msc||Harvard Medical School, Boston Children’s Hospital, USA|
|Darrell Wilson, MD||Stanford University, USA|
Guidelines for Submitting a Manuscript
After reading the guidelines, please submit to the manuscript central site.
JDST authors have the option to make their articles open access via SAGE Choice for $3,000. Learn more about SAGE Choice
JDST authors may fast track their articles to publication by paying the journal’s Fast Track fee of $3,000. Please contact our journal staff if you are interested in the Fast Track option upon submission.
Topics of Interest
Journal of Diabetes Science and Technology (DST) welcomes the submission of manuscripts with accompanying figures and tables whose topics relate to the study and treatment of diabetes:
- Glucose monitoring
- Insulin and metabolic peptide delivery
- Artificial and bioartificial pancreas
- Information technology
- Software for modeling
- Physiologic monitoring
- Technology for managing obesity
- Diagnostic tests of glycation
- Personalized medicine for diabetes, including pharmacogenomics and biomarkers
- Technology for improving adherence to therapy
- Use of bioengineered tools such as
- New biomaterials
- Nanotechnology in the development of sensors and actuators
Journal of Diabetes Science and Technology features articles that cover basic research and clinical applications of technology that are being developed to help people with diabetes.
If you or your funder wish your article to be freely available online to nonsubscribers immediately upon publication (gold open access), you can opt for it to be included in SAGE Choice, subject to payment of a publication fee. The manuscript submission and peer review procedure is unchanged. On acceptance of your article, you will be asked to let SAGE know directly if you are choosing SAGE Choice. To check journal eligibility and the publication fee, please visit SAGE Choice. For more information on open access options and compliance at SAGE, including self author archiving deposits (green open access) visit SAGE Publishing Policies on our Journal Author Gateway.